AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Frey-Met G1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Algen Healthcare Limited

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Frey-Met G1 Tablet SR

Glimepiride-Metformin Extended-Release tablets are classified as antidiabetic agents, a combination therapy for adult-onset type 2 diabetes. This medication helps regulate blood glucose. Administer this medicine with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation can elevate blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication is one component of a comprehensive diabetes management plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent side effect, manifesting as sweating, dizziness, headache, and tremors. Maintain regular mealtimes and carry a readily available fast-acting glucose source (e.g., sugary snacks, juice). Alcohol consumption increases hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation before use. Regular blood glucose monitoring, along with periodic blood tests to assess blood cell counts and liver function, are recommended.

Uses of Frey-Met G1 Tablet SR

Managing type 2 diabetes

Major Benefits of Frey-Met G1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Frey-Met G1 Tablet SR. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.

Common Side effects of Frey-Met G1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Frey-Met G1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Frey-Met G1 Tablet SR. Ingest the tablet whole; do not crush, chew, or divide it. This medication should be taken with a meal.

How Frey-Met G1 Tablet SR works:

Frey-Met G1 SR tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol and Frey-Met G1 Tablet SR should not be consumed together due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Frey-Met G1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice.

Breast feedingBreast feedingUNSAFE

The extended-release Frey-Met G1 Tablet is contraindicated for use while breastfeeding due to the potential for infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Exercise caution when administering Frey-Met G1 Tablet SR to individuals with impaired renal function; dosage modification may be necessary. Physician consultation is recommended. Frey-Met G1 Tablet SR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is advised during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Frey-Met G1 Tablet SR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For individuals with mild to moderate liver disease, Frey-Met G1 Tablet SR is typically initiated at a low dose; however, its use is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Frey-Met G1 Tablet SR :

Should you forget a dose of Frey-Met G1 Tablet SR, take it immediately if you remember. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing pattern. Never take a double dose.

Facts to Know About Frey-Met G1 Tablet SR

LabelValue
Addictive None.
Type of Medication Medication for diabetes

FAQs on Frey-Met G1 Tablet SR

Retain this medication within its original, sealed container. Store as directed on the packaging or label. Discard any leftover medication. Ensure it remains inaccessible to children, pets, and others.
Indeed, Frey-Met G1 Tablet SR carries a risk of lactic acidosis, a serious medical condition characterized by excessive blood lactic acid. Also termed MALA (Metformin-associated lactic acidosis), this rare adverse reaction is particularly dangerous for individuals with pre-existing kidney impairment, the elderly, or those who consume substantial alcohol. Manifestations of lactic acidosis can encompass muscle aches or weakness, vertigo, fatigue, cold extremities, respiratory distress, nausea, emesis, abdominal discomfort, and bradycardia. Should these symptoms arise, discontinue Frey-Met G1 Tablet SR and seek prompt medical attention.
Frey-Met G1 SR tablets contain glimepiride and metformin, acting together to manage type 2 diabetes mellitus in adults. This dual therapy enhances glycemic control when combined with a healthy diet and physical activity. Glimepiride stimulates pancreatic insulin secretion, reducing blood glucose. Metformin concurrently decreases hepatic glucose output and improves insulin responsiveness. This formulation is unsuitable for type 1 diabetes.
Frey-Met G1 Tablet SR administration may result in frequent side effects including hypoglycemia, altered taste perception, nausea, abdominal discomfort, diarrhea, and cephalalgia. Rare, but potentially serious adverse reactions such as lactic acidosis may occur. Prolonged therapy may additionally cause vitamin B12 deficiency.
Prolonged Frey-Met G1 Tablet SR use can indeed lead to Vitamin B12 deficiency by impeding its gastric absorption. This deficiency, if left unaddressed, may result in anemia, neurological complications such as paresthesia in the extremities, generalized weakness, urinary dysfunction, cognitive changes, and ataxia. Consequently, supplemental Vitamin B12 intake, at least annually, is recommended by some experts to mitigate these risks.
Indeed, Frey-Met G1 Tablet SR can induce hypoglycemia, characterized by low blood glucose. Manifestations of this condition may encompass nausea, headache, irritability, increased appetite, diaphoresis, vertigo, tachycardia, and feelings of apprehension or tremor. The likelihood of hypoglycemia increases with skipped or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Carrying a readily available source of glucose, such as glucose tablets, honey, or fruit juice, is advisable.
Consuming Frey-Met G1 Tablet SR concurrently with alcohol is inadvisable due to the risk of reduced blood glucose, potentially causing hypoglycemia. Furthermore, this combination may elevate the likelihood of lactic acidosis.
Frey-Met G1 Tablet SR
53
MRP 65
18% off